Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of XH-S004 tablets in non-cystic fibrosis bronchiectasis
CTR20251293Phase 2Active
- Sponsor
- Xinghao Pengbo
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XH-S004 in bronchiectasis, sponsored by Xinghao Pengbo. Started May 2025; status: active.
02
Drugs
XH-S004
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20251293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251293.